Ocular Surface Research entered the industry of Physicians Offices in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Physicians Offices. For further clarification, the SIC classifies this business under the code 8011 and described it as a Physicians Offices. The business provides service to the B2C market.
To acquire more information, please contact Scheffer Tseng by calling (305) 274-1299 during business hours. You can also write to the business’ Single Location at 8780 Sw 92nd St # 203, Miami, Florida FL 33176. You can also visit the company’s website at ocularsurface.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Ocular Surface Research |
| Representative: | Scheffer Tseng |
| Place of Business: | 8780 Sw 92nd St # 203, Miami, FL 33176 |
| Contact Number: | (305) 274-1299 |
| Website: | ocularsurface.com |
| Type of Service: | Physicians Offices |
| SIC Number: | 8011 |
| NAICS Number: | 621111 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2001 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Ocular Surface Research is a company operating from Miami-Dade, Florida providing professional Physicians Offices and relevant B2C variables. It was founded in 2001 and registered with the SIC code 8011 as Physicians Offices, and with the NAICS code 621111 as Physicians Offices.
With a current employee count of 1 to 4, Ocular Surface Research has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Scheffer Tseng at (305) 274-1299 for related queries, or to locate its Single Location using the coordinates 25.684218,-80.336444.
The Single Location can also be found at the street address 8780 Sw 92nd St # 203 in Miami, Florida 33176 and can be engaged online through the company website at ocularsurface.com, the company Twitter , and Facebook page .